Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Journal De La Societe De Biologie
|
August 24, 2005
[Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene]
Frédéric Chevessier, Brice Faraut, Aymeric Ravel-Chapuis, et al.
Scientific Reports
|
December 1, 2023
Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease
Matthieu Béreau, Anna Castrioto, Mathieu Servant, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 25, 2017
A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease
Christophe Verny, Anne-Catherine Bachoud-Lévi, Alexandra Durr, et al.
Human Molecular Genetics
|
October 22, 2004
MUSK, a new target for mutations causing congenital myasthenic syndrome
Frédéric Chevessier, Brice Faraut, Aymeric Ravel-Chapuis, et al.
Fundamental & Clinical Pharmacology
|
January 12, 2011
Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals
Elisabeth Frauger, Jerome Grassi, Vincent Pradel, et al.
Parkinsonism & Related Disorders
|
October 10, 2018
Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial
Jean-Christophe Corvol, Franck Durif, Wassilios G Meissner, et al.
Biomed Research International
|
May 9, 2018
Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study
Eric Hachulla, Gwendal Le Masson, Guilhem Solé, et al.
Journal of Neurology
|
December 3, 2014
Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice
Mathilde Renaud, Julien Perriard, Sarah Coudray, et al.
Plos One
|
September 23, 2016
COMT Val158Met Polymorphism Modulates Huntington's Disease Progression
Ruth de Diego-Balaguer, Catherine Schramm, Isabelle Rebeix, et al.
Fundamental & Clinical Pharmacology
|
March 10, 2025
Use and misuse of domperidone in patients living with Parkinson disease in France
Edouard Januel, Jean Christophe Corvol, Philippe Remy, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Journal De La Societe De Biologie
|
August 24, 2005
[Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene]
Frédéric Chevessier, Brice Faraut, Aymeric Ravel-Chapuis, et al.
Scientific Reports
|
December 1, 2023
Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease
Matthieu Béreau, Anna Castrioto, Mathieu Servant, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 25, 2017
A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease
Christophe Verny, Anne-Catherine Bachoud-Lévi, Alexandra Durr, et al.
Human Molecular Genetics
|
October 22, 2004
MUSK, a new target for mutations causing congenital myasthenic syndrome
Frédéric Chevessier, Brice Faraut, Aymeric Ravel-Chapuis, et al.
Fundamental & Clinical Pharmacology
|
January 12, 2011
Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals
Elisabeth Frauger, Jerome Grassi, Vincent Pradel, et al.
Parkinsonism & Related Disorders
|
October 10, 2018
Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial
Jean-Christophe Corvol, Franck Durif, Wassilios G Meissner, et al.
Biomed Research International
|
May 9, 2018
Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study
Eric Hachulla, Gwendal Le Masson, Guilhem Solé, et al.
Journal of Neurology
|
December 3, 2014
Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice
Mathilde Renaud, Julien Perriard, Sarah Coudray, et al.
Plos One
|
September 23, 2016
COMT Val158Met Polymorphism Modulates Huntington's Disease Progression
Ruth de Diego-Balaguer, Catherine Schramm, Isabelle Rebeix, et al.
Fundamental & Clinical Pharmacology
|
March 10, 2025
Use and misuse of domperidone in patients living with Parkinson disease in France
Edouard Januel, Jean Christophe Corvol, Philippe Remy, et al.
Page
of 11